We’re dedicated to supporting cutting-edge diabetes research and improving the lives of people with diabetes. And it’s only thanks to clinical trials that new treatments and therapies can become available. It was International Clinical Trials Day on Saturday and we’d like to take this opportunity to send a big thank you to everyone who put themselves…
In a regular blog series, Simon O’Neill, Diabetes UK’s Director of Health Intelligence and Professional Liaison, rounds up the latest diabetes news. This week Simon updates on new research developments. Diabetes deaths Traditionally it has been very difficult to get an accurate record of the numbers of deaths related to diabetes. This is because diabetes…
In a regular blog series, Simon O’Neill, Diabetes UK’s Director of Health Intelligence and Professional Liaison, rounds up the latest diabetes news. This week Simon looks at new food structures, healthcare technologies and recommendations. Sugar lite? At the end of 2016, Nestlé announced that it has developed a way of restructuring sugar, so that it can break…
Hi, I’m Emma. I’m the Editor and Content Producer for Enjoy Food here at Diabetes UK. Enjoy Food is our source of healthy eating information and advice, designed to help families living with diabetes to shop, cook and eat with confidence and success. Managing diet, and understanding what to eat when you have diabetes, is…
In a regular blog series, Simon O’Neill, Diabetes UK’s Director of Health Intelligence and Professional Liaison, rounds up the latest diabetes news. This week Simon rounds up the latest technologies, medicines and treatments. Ultra Rapid Insulin Eli Lilly have announced that they are ending their licensing agreement for ultra-rapid-acting insulin BioChaperone Lispro. The company that developed this insulin,…
You might have seen my blog about the highlights for Type 1 diabetes research presented at the Diabetes UK Professional Conference. But there’s a lot going on with Type 2 as well. There can be lots of different treatment options for people with Type 2 diabetes, so the idea of personalising medicine to give the…